We next treated immunodeficient mice engrafted with HLA-A*24:02 (SKNAS and COG-564x) and HLA-A*23:01 (NBSD) xenografts with 106 10LH and 302LH transduced CAR T cells once tumours reached 100–250 mm3. This evidence concerns the gene HLA-A and neoplasm.